Since the early discoveries of ZBTB16 in APL and BCL6 in B-cell lymphomas and leukemias, an increasing number of studies have focused on the roles of ZBTB proteins in hematological malignancies. Here, BCL6 is linked to B-cell non-Hodgkin lymphoma.